MAT
58
2
STT
48
11
PPL
52
2
IPG
49
2
MDLZ
55
2
EXR
33
-4
TRV
43
-7
EFX
54
-11
FOX
33
3
NVDA
56
2
PG
45
2
TRIP
50
-2
PM
50
5
WY
50
2
CMA
42
2
KO
47
3
CNX
65
-3
UNH
46
4
NTAP
60
-4
PAYX
41
-4
MAT
58
2
STT
48
11
PPL
52
2
IPG
49
2
MDLZ
55
2
EXR
33
-4
TRV
43
-7
EFX
54
-11
FOX
33
3
NVDA
56
2
PG
45
2
TRIP
50
-2
PM
50
5
WY
50
2
CMA
42
2
KO
47
3
CNX
65
-3
UNH
46
4
NTAP
60
-4
PAYX
41
-4
Financhill
Back

Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

NOW is the time to get in on this trillion-dollar megatrend

Get it here.
Buy
58

REGN
Regeneron Pharmaceuticals

Last Price:
896.26
Seasonality Move:
12.22%

7 Day Trial

ALL ACCESS PASS

$ 7

$50 trade to make today with huge potential!

Click here to access my #1 options strategy for overnight wins starting with $50!

Regeneron Pharmaceuticals Price Quote

$896.26
+2.76 (+0.31%)
(Updated: April 19, 2024 at 6:55 PM ET)

Regeneron Pharmaceuticals Key Stats

Buy
58
Regeneron Pharmaceuticals (REGN) is a Buy
Day range:
$891.67 - $908.81
52-week range:
$684.81 - $998.33
Dividend yield:
0%
P/E ratio:
25.70
P/S ratio:
7.75
P/B ratio:
3.78%
Volume:
363.7K
Avg. volume:
444.5K
1-year change:
10.58%
Market cap:
$98.1B
Revenue:
$13.1B
EPS:
$34.75

How Much Does Regeneron Pharmaceuticals Make?

Is Regeneron Pharmaceuticals Growing As A Company?

Regeneron Pharmaceuticals Stock Price Performance

What Is Regeneron Pharmaceuticals 52-Week High & Low?

Regeneron Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Regeneron Pharmaceuticals?

Is Regeneron Pharmaceuticals Cash Flow Positive?

  • What Is REGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.6B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.8B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.2B

Regeneron Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    REGN return on invested capital is 15.09%
  • What Is Regeneron Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 12.74%
  • What Is REGN Return On Equity?
    ROE is a measure of profitability and is 16.33%

Regeneron Pharmaceuticals Earnings Date & Stock Price

Regeneron Pharmaceuticals Competitors

Regeneron Pharmaceuticals Dividend Yield

Data Unavailable

Regeneron Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: -2.95% 10.37%
Revenue: 0.58% 4.49%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 1,035.32
Upside from Last Price: 15.87%

Major Shareholders

  • How many REGN shares are owned by institutional investors?
    167.6M REGN shares are owned by institutional investors
  • How many REGN shares are owned by insiders?
    2M REGN shares are owned by insiders